Levi & Korsinsky is investigating the Board of Directors of Martek Biosciences Corporation (“Martek” or the “Company”) (NasdaqGS: MATK) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Royal DSM N.V. (“DSM”) (NYSE: DSM). Under the terms of the transaction, DSM stockholders will receive $31.50 in cash for each outstanding share of DSM stock they own for a total transaction value of approximately $1.09 billion.

Click here to learn how to join the action: http://www.zlk.com/martek-matk.html, or call: 877-363-5972.

The investigation concerns whether the Martek Board of Directors breached their fiduciary duties to Martek stockholders by failing to adequately shop the Company before entering into this transaction and whether DSM is underpaying for Martek shares, thus unlawfully harming Martek stockholders.

If you own common stock in Martek and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/martek-matk.html.

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Martek (NASDAQ:MATK)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Martek Charts.
Martek (NASDAQ:MATK)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Martek Charts.